PROK
ProKidney Corp.
NASDAQ: PROK · HEALTHCARE · BIOTECHNOLOGY
$1.82
-0.55% today
Updated 2026-04-29
Market cap
$552.59M
P/E ratio
—
P/S ratio
618.80x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $6
Volume
0.8M
ProKidney Corp. (PROK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-20,306.00%
ROE
-43.20%
ROA
-26.60%
Debt/equity
-0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-79.61M | — | — | — |
| 2020 | $0.00 | $-26.75M | — | — | — |
| 2021 | $0.00 | $-55.15M | — | — | — |
| 2022 | $0.00 | $-108.03M | — | — | — |
| 2023 | $0.00 | $-35.47M | — | — | — |
| 2024 | $76000.00 | $-61.19M | 100.00% | -241,678.95% | -80,507.89% |
| 2025 | $893000.00 | $-68.99M | -540.76% | -18,477.83% | -7,725.20% |